Presage Biosciencesincis A Biotechnology Company Based In Seattlewashingtonfounded In 2008The Company Specializes In Translational Oncologyfocusing On Advancing Cancer Drug Development Through Its Proprietary Civoa C Platformthis Innovative Technology Allows For Precision Drug Response Evaluation Directly Within Human Tumorsproviding Valuable Insights Into Tumor Biology The Civoa C Platform Enables Simultaneous Testing Of Multiple Drugs Or Rna Interference Agents In Tumorshelping To Identify Effective Drug Candidates And Combinations While Minimizing Systemic Toxicitypresage Supports Both Preclinical Research And Clinical Trialswith Applications In Various Cancersincluding Soft Tissue Sarcoma And Head Neck Cancersthe Company Collaborates With Pharmaceutical Partners Like Celgene Corporation And Takeda Oncology To Enhance Drug Efficacy Testing And Develop Combination Therapiespresage Aims To Reduce Late Stage Drug Attrition By Delivering Early Human Tumor Efficacy Dataestablishing Itself As A Key Player In Precision Oncology
No conferences found for this company.
| Company Name | Presage Biosciences Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
